Here, we selected tumor immunity-related biological markers, including CD8, FOXP3, and CD163, which, respectively, represented CD8+ T cells, FOXP3+ Treg cells, and CD163+ M2 macrophages to analyze different advanced GC types. This evidence concerns the gene CD163 and gastric cancer.